The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-aging Drugs Market Research Report 2025
Synopsis
Botox and filler treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging.
The global Anti-aging Drugs market was valued at US$ 8823.1 million in 2023 and is anticipated to reach US$ 19560 million by 2030, witnessing a CAGR of 11.9% during the forecast period 2024-2030.
The industry's leading producers are Allergan, Galderma and LG Life Science, with revenue ratios of 41.40%, 16.45% and 8.36%, respectively, in 2019.
This report aims to provide a comprehensive presentation of the global market for Anti-aging Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-aging Drugs.
Report Scope
The Anti-aging Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-aging Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-aging Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Galderma
LG Life Science
Merz Pharma
Medytox
Hugel
IMEIK
Haohai Bio
Daewoong Pharmaceutical
Bloomage
Suneva Medical
SciVision Biotech
Segment by Type
Dermal Fillers
Botulinum Toxin
Others
Segment by Application
Hospital
Beauty Parlor
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-aging Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-aging Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Botox and filler treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging.
The global Anti-aging Drugs market was valued at US$ 8823.1 million in 2023 and is anticipated to reach US$ 19560 million by 2030, witnessing a CAGR of 11.9% during the forecast period 2024-2030.
The industry's leading producers are Allergan, Galderma and LG Life Science, with revenue ratios of 41.40%, 16.45% and 8.36%, respectively, in 2019.
This report aims to provide a comprehensive presentation of the global market for Anti-aging Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-aging Drugs.
Report Scope
The Anti-aging Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-aging Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-aging Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Galderma
LG Life Science
Merz Pharma
Medytox
Hugel
IMEIK
Haohai Bio
Daewoong Pharmaceutical
Bloomage
Suneva Medical
SciVision Biotech
Segment by Type
Dermal Fillers
Botulinum Toxin
Others
Segment by Application
Hospital
Beauty Parlor
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-aging Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-aging Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Anti-aging Drugs Market Overview
1.1 Product Overview and Scope of Anti-aging Drugs
1.2 Anti-aging Drugs Segment by Type
1.2.1 Global Anti-aging Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Dermal Fillers
1.2.3 Botulinum Toxin
1.2.4 Others
1.3 Anti-aging Drugs Segment by Application
1.3.1 Global Anti-aging Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Beauty Parlor
1.3.4 Others
1.4 Global Anti-aging Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-aging Drugs Revenue 2019-2030
1.4.2 Global Anti-aging Drugs Sales 2019-2030
1.4.3 Global Anti-aging Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-aging Drugs Market Competition by Manufacturers
2.1 Global Anti-aging Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-aging Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-aging Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Anti-aging Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-aging Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-aging Drugs, Product Type & Application
2.7 Anti-aging Drugs Market Competitive Situation and Trends
2.7.1 Anti-aging Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-aging Drugs Players Market Share by Revenue
2.7.3 Global Anti-aging Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-aging Drugs Retrospective Market Scenario by Region
3.1 Global Anti-aging Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-aging Drugs Global Anti-aging Drugs Sales by Region: 2019-2030
3.2.1 Global Anti-aging Drugs Sales by Region: 2019-2024
3.2.2 Global Anti-aging Drugs Sales by Region: 2025-2030
3.3 Global Anti-aging Drugs Global Anti-aging Drugs Revenue by Region: 2019-2030
3.3.1 Global Anti-aging Drugs Revenue by Region: 2019-2024
3.3.2 Global Anti-aging Drugs Revenue by Region: 2025-2030
3.4 North America Anti-aging Drugs Market Facts & Figures by Country
3.4.1 North America Anti-aging Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-aging Drugs Sales by Country (2019-2030)
3.4.3 North America Anti-aging Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-aging Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-aging Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-aging Drugs Sales by Country (2019-2030)
3.5.3 Europe Anti-aging Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-aging Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-aging Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-aging Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-aging Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-aging Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-aging Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-aging Drugs Sales by Country (2019-2030)
3.7.3 Latin America Anti-aging Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-aging Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-aging Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-aging Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-aging Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-aging Drugs Sales by Type (2019-2030)
4.1.1 Global Anti-aging Drugs Sales by Type (2019-2024)
4.1.2 Global Anti-aging Drugs Sales by Type (2025-2030)
4.1.3 Global Anti-aging Drugs Sales Market Share by Type (2019-2030)
4.2 Global Anti-aging Drugs Revenue by Type (2019-2030)
4.2.1 Global Anti-aging Drugs Revenue by Type (2019-2024)
4.2.2 Global Anti-aging Drugs Revenue by Type (2025-2030)
4.2.3 Global Anti-aging Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Anti-aging Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-aging Drugs Sales by Application (2019-2030)
5.1.1 Global Anti-aging Drugs Sales by Application (2019-2024)
5.1.2 Global Anti-aging Drugs Sales by Application (2025-2030)
5.1.3 Global Anti-aging Drugs Sales Market Share by Application (2019-2030)
5.2 Global Anti-aging Drugs Revenue by Application (2019-2030)
5.2.1 Global Anti-aging Drugs Revenue by Application (2019-2024)
5.2.2 Global Anti-aging Drugs Revenue by Application (2025-2030)
5.2.3 Global Anti-aging Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Anti-aging Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan Anti-aging Drugs Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Galderma
6.2.1 Galderma Corporation Information
6.2.2 Galderma Description and Business Overview
6.2.3 Galderma Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Galderma Anti-aging Drugs Product Portfolio
6.2.5 Galderma Recent Developments/Updates
6.3 LG Life Science
6.3.1 LG Life Science Corporation Information
6.3.2 LG Life Science Description and Business Overview
6.3.3 LG Life Science Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 LG Life Science Anti-aging Drugs Product Portfolio
6.3.5 LG Life Science Recent Developments/Updates
6.4 Merz Pharma
6.4.1 Merz Pharma Corporation Information
6.4.2 Merz Pharma Description and Business Overview
6.4.3 Merz Pharma Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merz Pharma Anti-aging Drugs Product Portfolio
6.4.5 Merz Pharma Recent Developments/Updates
6.5 Medytox
6.5.1 Medytox Corporation Information
6.5.2 Medytox Description and Business Overview
6.5.3 Medytox Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Medytox Anti-aging Drugs Product Portfolio
6.5.5 Medytox Recent Developments/Updates
6.6 Hugel
6.6.1 Hugel Corporation Information
6.6.2 Hugel Description and Business Overview
6.6.3 Hugel Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hugel Anti-aging Drugs Product Portfolio
6.6.5 Hugel Recent Developments/Updates
6.7 IMEIK
6.6.1 IMEIK Corporation Information
6.6.2 IMEIK Description and Business Overview
6.6.3 IMEIK Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 IMEIK Anti-aging Drugs Product Portfolio
6.7.5 IMEIK Recent Developments/Updates
6.8 Haohai Bio
6.8.1 Haohai Bio Corporation Information
6.8.2 Haohai Bio Description and Business Overview
6.8.3 Haohai Bio Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Haohai Bio Anti-aging Drugs Product Portfolio
6.8.5 Haohai Bio Recent Developments/Updates
6.9 Daewoong Pharmaceutical
6.9.1 Daewoong Pharmaceutical Corporation Information
6.9.2 Daewoong Pharmaceutical Description and Business Overview
6.9.3 Daewoong Pharmaceutical Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Daewoong Pharmaceutical Anti-aging Drugs Product Portfolio
6.9.5 Daewoong Pharmaceutical Recent Developments/Updates
6.10 Bloomage
6.10.1 Bloomage Corporation Information
6.10.2 Bloomage Description and Business Overview
6.10.3 Bloomage Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bloomage Anti-aging Drugs Product Portfolio
6.10.5 Bloomage Recent Developments/Updates
6.11 Suneva Medical
6.11.1 Suneva Medical Corporation Information
6.11.2 Suneva Medical Anti-aging Drugs Description and Business Overview
6.11.3 Suneva Medical Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Suneva Medical Anti-aging Drugs Product Portfolio
6.11.5 Suneva Medical Recent Developments/Updates
6.12 SciVision Biotech
6.12.1 SciVision Biotech Corporation Information
6.12.2 SciVision Biotech Anti-aging Drugs Description and Business Overview
6.12.3 SciVision Biotech Anti-aging Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 SciVision Biotech Anti-aging Drugs Product Portfolio
6.12.5 SciVision Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-aging Drugs Industry Chain Analysis
7.2 Anti-aging Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-aging Drugs Production Mode & Process
7.4 Anti-aging Drugs Sales and Marketing
7.4.1 Anti-aging Drugs Sales Channels
7.4.2 Anti-aging Drugs Distributors
7.5 Anti-aging Drugs Customers
8 Anti-aging Drugs Market Dynamics
8.1 Anti-aging Drugs Industry Trends
8.2 Anti-aging Drugs Market Drivers
8.3 Anti-aging Drugs Market Challenges
8.4 Anti-aging Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Anti-aging Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Anti-aging Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Anti-aging Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Anti-aging Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Anti-aging Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Anti-aging Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Anti-aging Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Anti-aging Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Anti-aging Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-aging Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-aging Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Anti-aging Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-aging Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-aging Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-aging Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Anti-aging Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Anti-aging Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Anti-aging Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Anti-aging Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Anti-aging Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Anti-aging Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Anti-aging Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Anti-aging Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Anti-aging Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Anti-aging Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Anti-aging Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Anti-aging Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Anti-aging Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Anti-aging Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Anti-aging Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Anti-aging Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Anti-aging Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Anti-aging Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Anti-aging Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Anti-aging Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Anti-aging Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Anti-aging Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Anti-aging Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-aging Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Anti-aging Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Anti-aging Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Anti-aging Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti-aging Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Anti-aging Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Anti-aging Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Anti-aging Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Anti-aging Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Anti-aging Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Anti-aging Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Anti-aging Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Anti-aging Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Anti-aging Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Anti-aging Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Anti-aging Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Anti-aging Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Anti-aging Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Anti-aging Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Anti-aging Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Anti-aging Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Anti-aging Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Anti-aging Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Anti-aging Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Anti-aging Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Anti-aging Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Anti-aging Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Anti-aging Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Anti-aging Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Anti-aging Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. Allergan Corporation Information
Table 71. Allergan Description and Business Overview
Table 72. Allergan Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Allergan Anti-aging Drugs Product
Table 74. Allergan Recent Developments/Updates
Table 75. Galderma Corporation Information
Table 76. Galderma Description and Business Overview
Table 77. Galderma Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Galderma Anti-aging Drugs Product
Table 79. Galderma Recent Developments/Updates
Table 80. LG Life Science Corporation Information
Table 81. LG Life Science Description and Business Overview
Table 82. LG Life Science Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. LG Life Science Anti-aging Drugs Product
Table 84. LG Life Science Recent Developments/Updates
Table 85. Merz Pharma Corporation Information
Table 86. Merz Pharma Description and Business Overview
Table 87. Merz Pharma Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Merz Pharma Anti-aging Drugs Product
Table 89. Merz Pharma Recent Developments/Updates
Table 90. Medytox Corporation Information
Table 91. Medytox Description and Business Overview
Table 92. Medytox Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Medytox Anti-aging Drugs Product
Table 94. Medytox Recent Developments/Updates
Table 95. Hugel Corporation Information
Table 96. Hugel Description and Business Overview
Table 97. Hugel Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Hugel Anti-aging Drugs Product
Table 99. Hugel Recent Developments/Updates
Table 100. IMEIK Corporation Information
Table 101. IMEIK Description and Business Overview
Table 102. IMEIK Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. IMEIK Anti-aging Drugs Product
Table 104. IMEIK Recent Developments/Updates
Table 105. Haohai Bio Corporation Information
Table 106. Haohai Bio Description and Business Overview
Table 107. Haohai Bio Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Haohai Bio Anti-aging Drugs Product
Table 109. Haohai Bio Recent Developments/Updates
Table 110. Daewoong Pharmaceutical Corporation Information
Table 111. Daewoong Pharmaceutical Description and Business Overview
Table 112. Daewoong Pharmaceutical Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Daewoong Pharmaceutical Anti-aging Drugs Product
Table 114. Daewoong Pharmaceutical Recent Developments/Updates
Table 115. Bloomage Corporation Information
Table 116. Bloomage Description and Business Overview
Table 117. Bloomage Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Bloomage Anti-aging Drugs Product
Table 119. Bloomage Recent Developments/Updates
Table 120. Suneva Medical Corporation Information
Table 121. Suneva Medical Description and Business Overview
Table 122. Suneva Medical Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Suneva Medical Anti-aging Drugs Product
Table 124. Suneva Medical Recent Developments/Updates
Table 125. SciVision Biotech Corporation Information
Table 126. SciVision Biotech Description and Business Overview
Table 127. SciVision Biotech Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. SciVision Biotech Anti-aging Drugs Product
Table 129. SciVision Biotech Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Anti-aging Drugs Distributors List
Table 133. Anti-aging Drugs Customers List
Table 134. Anti-aging Drugs Market Trends
Table 135. Anti-aging Drugs Market Drivers
Table 136. Anti-aging Drugs Market Challenges
Table 137. Anti-aging Drugs Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-aging Drugs
Figure 2. Global Anti-aging Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anti-aging Drugs Market Share by Type in 2023 & 2030
Figure 4. Dermal Fillers Product Picture
Figure 5. Botulinum Toxin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Anti-aging Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Anti-aging Drugs Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Beauty Parlor
Figure 11. Others
Figure 12. Global Anti-aging Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Anti-aging Drugs Market Size (2019-2030) & (US$ Million)
Figure 14. Global Anti-aging Drugs Sales (2019-2030) & (K Units)
Figure 15. Global Anti-aging Drugs Average Price (US$/Unit) & (2019-2030)
Figure 16. Anti-aging Drugs Report Years Considered
Figure 17. Anti-aging Drugs Sales Share by Manufacturers in 2023
Figure 18. Global Anti-aging Drugs Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Anti-aging Drugs Players: Market Share by Revenue in 2023
Figure 20. Anti-aging Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Anti-aging Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Anti-aging Drugs Sales Market Share by Country (2019-2030)
Figure 23. North America Anti-aging Drugs Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Anti-aging Drugs Sales Market Share by Country (2019-2030)
Figure 27. Europe Anti-aging Drugs Revenue Market Share by Country (2019-2030)
Figure 28. Germany Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Anti-aging Drugs Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Anti-aging Drugs Revenue Market Share by Region (2019-2030)
Figure 35. China Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Anti-aging Drugs Sales Market Share by Country (2019-2030)
Figure 46. Latin America Anti-aging Drugs Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Anti-aging Drugs Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Anti-aging Drugs Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Anti-aging Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Anti-aging Drugs by Type (2019-2030)
Figure 56. Global Revenue Market Share of Anti-aging Drugs by Type (2019-2030)
Figure 57. Global Anti-aging Drugs Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Anti-aging Drugs by Application (2019-2030)
Figure 59. Global Revenue Market Share of Anti-aging Drugs by Application (2019-2030)
Figure 60. Global Anti-aging Drugs Price (US$/Unit) by Application (2019-2030)
Figure 61. Anti-aging Drugs Value Chain
Figure 62. Anti-aging Drugs Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
